MHRA approves licence 8th August 2018

MHRA approves licence 8th August 2018

Biotherapy Services Limited

 

MHRA approves licence MIA/(IMP) for the point-of-care manufacture of RAPIDTM Biodynamic Haematogel treatment.

 

Biotherapy Services Ltd. announces the granting of the MIA/(IMP) and “Specials” licences for our proprietary RAPIDTM Biodynamic Haematogel wound care treatment for complex and chronic wounds, was issued on 8thAugust 2018

 

For further information, please contact:

Biotherapy Services Ltd

Janet Hadfield, Chief Executive Officer

Info@biotherapyservices.comTel: ++44 (0) 207 788 7828

 

No Comments

Post A Comment